Showing results (31-40 of 784,141) with videos related to
Sort By:
Pageof 78,415
Journal of Personalized Medicine|August 26, 2022
Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer CellsShiliu Tian, Rui Su, Ke Wu, et al.Oncology Letters|January 16, 2023
Genetic variants in African-American and Hispanic patients with breast cancerPranabananda Dutta, Man Y Keung, Yanyuan Wu, et al.Research in Social & Administrative Pharmacy : RSAP|October 10, 2022
Social determinants predict whether Medicare beneficiaries are offered a Comprehensive Medication ReviewMerton Lee, Barbara J Zarowitz, Karen Pellegrin, et al.Journal of Personalized Medicine|February 26, 2026
Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318Shiliu Tian, Rui Su, Ke Wu, et al.JPEN. Journal of Parenteral and Enteral Nutrition|January 1, 1994
Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndromeS J O'Keefe, M E Peterson, C R FlemingAnnales De Medecine Interne|January 1, 1979
[Two new cases of allergy to tartrazine (author's transl)]A PellegrinCancer Management and Research|November 23, 2018
Celecoxib in breast cancer prevention and therapyJieqing Li, Qiongyu Hao, Wei Cao, et al.Oncology|November 27, 1999
Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic womenJ V Vadgama, Y Wu, G Datta, et al.Apoptosis : an International Journal on Programmed Cell Death|December 30, 2006
Taxol induced apoptosis regulates amino acid transport in breast cancer cellsYanyuan Wu, Dejun Shen, Zujian Chen, et al.Breast Cancer Research and Treatment|May 16, 2015
Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killingYong Wu, Marianna Sarkissyan, Eva Mcghee, et al.Pageof 78,415